Alzheimer’S And Hormone Therapy

Recent studies suggest a potential link between hormone therapy and Alzheimer's disease and dementia. Hormone therapy, particularly estrogen, has been explored due to its role in brain health and cognitive function. Estrogen is believed to have neuroprotective effects, potentially reducing the risk of developing Alzheimer's disease by maintaining neuronal health and synaptic function. However, the relationship is complex, as hormone therapy's benefits may depend on various factors such as the timing of treatment initiation and duration. Some studies indicate that starting hormone therapy around the onset of menopause might be more beneficial for cognitive outcomes than starting later in life. Nonetheless, more research is needed to fully understand the effects of hormone therapy on Alzheimer's disease and dementia, including its long-term risks and benefits.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp